Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Molecular Oncology|May 10, 2020
Human fibronectin extra domain B as a biomarker for targeted therapy in cancerRelinde I Y Lieverse, Damiënne Marcus, Alexander M A van der Wiel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicityLinda Spiegelberg, Stefan J van Hoof, Rianne Biemans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 29, 2009
Glycolytic metabolism and tumour response to fractionated irradiationUlrike G A Sattler, Sandra S Meyer, Verena Quennet, et al.
Clinical and Translational Radiation Oncology|February 9, 2019
Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trialsLinda Spiegelberg, Ruud Houben, Raymon Niemans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 14, 2007
PAI-1 levels predict response to fractionated irradiation in 10 human squamous cell carcinoma lines of the head and neckChristine Bayer, Daniela Schilling, Joerg Hoetzel, et al.
The British Journal of Radiology|May 26, 2017
Combining radiotherapy with immunotherapy: the past, the present and the futureEvert J Van Limbergen, Dirk K De Ruysscher, Veronica Olivo Pimentel, et al.
International Journal of Radiation Oncology, Biology, Physics|April 26, 2011
Cellular and tumor radiosensitivity is correlated to epidermal growth factor receptor protein expression level in tumors without EGFR amplificationUlla Kasten-Pisula, Jarob Saker, Wolfgang Eicheler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2017
Ex vivo γH2AX radiation sensitivity assay in prostate cancer: Inter-patient and intra-patient heterogeneityChiara De-Colle, Ala Yaromina, Joerg Hennenlotter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2006
Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studiesAla Yaromina, Daniel Zips, Howard D Thames, et al.
Journal for Immunotherapy of Cancer|March 10, 2021
Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19-IL2 cures poorly immunogenic tumors when combined with radiotherapyVeronica Olivo Pimentel, Damiënne Marcus, Alexander Ma van der Wiel, et al.
Pageof 9